Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study
about
sameAs
Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteriaVitamin A and Alzheimer's diseaseMedications and DietPrevention of Alzheimer's diseaseAspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's diseaseNo advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studiesDiagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer diseaseNSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivoEffect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studiesVascular consequences of passive Abeta immunization for Alzheimer's disease. Is avoidance of "malactivation" of microglia enough?Nonsteroidal anti-inflammatory drug use and Alzheimer's disease risk: the MIRAGE StudyThe microglial "activation" continuum: from innate to adaptive responsesPopulation-based neuropathological studies of dementia: design, methods and areas of investigation--a systematic reviewGenetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and TauopathiesInhibition of microglia activation as a phenotypic assay in early drug discoveryAlzheimer's disease and type 2 diabetes via chronic inflammatory mechanismsNon-steroidal anti-inflammatory drugs mediate increased in vitro glial expression of apolipoprotein E proteinSingle oral dose study of two isosorbide-based aspirin prodrugs in the dogShould aspirin be used to counteract 'salicylate deficiency'?Effect of non-steroidal anti-inflammatory medications on the risk of amyotrophic lateral sclerosisBiphasic effect of aspirin on apoptosis of bovine vascular endothelial cells and its molecular mechanismEstrogen or estrogen receptor agonist inhibits lipopolysaccharide induced microglial activation and deathCommonly prescribed drugs associate with cognitive function: a cross-sectional study in UK BiobankShort-term treatment with tolfenamic acid improves cognitive functions in Alzheimer's disease miceThe amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy.Identification of cathepsin B as a mediator of neuronal death induced by Abeta-activated microglial cells using a functional genomics approach.Clinicopathological outcomes of prospectively followed normal elderly brain bank volunteers.A role for cyclooxygenase-1 in beta-amyloid-induced neuroinflammation.Can peripheral leukocytes be used as Alzheimer's disease biomarkers?Nonsteroidal anti-inflammatory drugs, aspirin, and cognitive function in the Baltimore longitudinal study of agingThe association between cognition and histamine-2 receptor antagonists in African Americans.Genetic aspects of behavioral neurotoxicologyThe Cache County Study on Memory in Aging: factors affecting risk of Alzheimer's disease and its progression after onsetNSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID typeCyclopentenone eicosanoids as mediators of neurodegeneration: a pathogenic mechanism of oxidative stress-mediated and cyclooxygenase-mediated neurotoxicity.Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging.Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids.Microglia activation mediates fibrillar amyloid-β toxicity in the aged primate cortex.Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseasesCognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib.
P2860
Q21245230-DA8D3594-7247-46B4-9A91-38172871074BQ22242414-F9851C9A-51B2-4409-BED3-C72E4B09CA3CQ22242806-989B7719-729F-4E49-9927-CE1AE64FE65BQ22248031-88F3952A-D743-4C59-9AFF-1B43AA9575CEQ24203739-9238F358-53C3-419D-A76E-506100482D75Q24642539-909B08AB-1C4F-4A3A-9238-9B7A164AA7B6Q24646877-943474D0-294C-4B99-8C84-5191BEC9E158Q24679444-1B213CA8-1FA8-4076-BB85-2A25108AB5F8Q24681261-695D69EE-BCAD-4272-A109-604EB002DF75Q24791744-5D03F29C-FAC9-49E2-8CCF-2D9656FEF2E4Q24792960-A9B71D4A-C329-4999-A80C-28B9480F3123Q24814335-6703ABD1-2750-482A-88F5-0FC17209B7F8Q25257388-1153253D-4A8C-462E-8E60-5A88485E4278Q26767289-441AD9AF-2CD0-4C6A-BF92-B23CF21328FCQ26996061-9B878593-29C2-43CE-BD81-D5A0AB71CCEAQ28086892-D24F094A-4078-46E3-910E-A96046D586EEQ28165456-D6FF978B-670F-4F34-9A98-2BDACAE89CDEQ28166016-C0F3848E-C5C2-4CCE-87A9-749BC688B1A8Q28166200-332DAD27-B4D8-4E43-B81D-83541AB9F028Q28211897-95073102-4E4F-432E-BDB6-3E7F27EBA346Q28219070-3CAB197A-287A-4E8C-B9E6-6850D7B23F47Q28577434-E64ABD8A-2D5C-4D66-AF1B-64D98212E57DQ28586171-A4AB8335-4FA1-4D1A-862D-B36492926E90Q30541295-92B3D38C-8D87-4C56-877D-0E89508A88B4Q30668465-635B07B7-DA5F-45B9-BC35-81FF2F06C0E8Q31023855-01DCD55A-A170-4AAD-80F2-E0393D183C0EQ33456273-E43B46E8-D283-40DB-9E3A-63301FDFAAA6Q33588710-41EEE045-A34E-4ADE-98BB-D523FB5F2215Q33689076-F6A23401-E99A-44AC-AFF7-61CB5DBFE1E4Q33706542-AFDDF628-6CA0-4DB5-AD6F-5AFEDFB7D093Q33814382-A8AC3C35-A8BD-46CE-B1F8-A1FAF34F42C3Q33863714-2E3E0381-0FE9-42E3-9119-39446B2D1907Q33873941-589C6E87-4353-49F7-8D71-A382E74490BAQ33881607-560F435C-ACA2-43D5-BB33-92263741505FQ33896920-97B3CD3A-FD48-476D-87D4-A62006EAACB5Q33904501-56C80ED6-275E-4B32-9838-D4E0E5CCD02CQ33914305-47D14AD8-26D7-4F29-BA87-B0CE7270866EQ33926543-FF01541A-5DAE-4B0F-8A1D-2BA4CDA3652DQ34071942-9BF24C3F-339E-46CF-AA1F-FC469FB82ADBQ34077849-C50B4F27-5DDF-414F-8E1B-D0237EF5F697
P2860
Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Reduced incidence of AD with N ...... onists: the Cache County Study
@ast
Reduced incidence of AD with N ...... onists: the Cache County Study
@en
Reduced incidence of AD with N ...... onists: the Cache County Study
@nl
type
label
Reduced incidence of AD with N ...... onists: the Cache County Study
@ast
Reduced incidence of AD with N ...... onists: the Cache County Study
@en
Reduced incidence of AD with N ...... onists: the Cache County Study
@nl
prefLabel
Reduced incidence of AD with N ...... onists: the Cache County Study
@ast
Reduced incidence of AD with N ...... onists: the Cache County Study
@en
Reduced incidence of AD with N ...... onists: the Cache County Study
@nl
P2093
P3181
P356
P1433
P1476
Reduced incidence of AD with N ...... onists: the Cache County Study
@en
P2093
James C Anthony
John C S Breitner
Kala Mehta
Kathleen M Hayden
Lawrence Mayer
Peter P Zandi
P3181
P356
10.1212/WNL.59.6.880
P407
P577
2002-09-24T00:00:00Z